Assessment of the Tolerability and Efficacy of Supplementation Containing Micronized and Emulsified Ferric Pyrophosphate in Patients with Iron Deficiency: An Observational Study

The study assessed the tolerability and efficacy of micronized and emulsified ferric pyrophosphate supplementation in 119 patients aged 19-70 with iron deficiency. After 3 months, 61.9% of women showed increased iron levels, and 57.6% of patients had increased ferritin levels. A significant 95.4% of participants reported a decrease in iron deficiency symptoms, although 38% experienced some discomfort during supplementation. Overall, 83.2% rated the supplement positively. The study concluded that this form of iron supplementation effectively improves laboratory results and reduces deficiency symptoms with good tolerance and minimal side effects.